Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market

AIM: To develop a new method of health-economic analysis based on a marginal approach. METHODS: We tested the research hypothesis that a detailed comparative a priori incremental cost-effectiveness analysis provides the necessary input for budget impact analysis about the proper order of introductio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mance, Diana, Mance, Davor, Vitezić, Dinko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2016
Materias:
Pharmacoeconomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209932/
https://www.ncbi.nlm.nih.gov/pubmed/28051283
http://dx.doi.org/10.3325/cmj.2016.57.582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209932/
https://www.ncbi.nlm.nih.gov/pubmed/28051283
http://dx.doi.org/10.3325/cmj.2016.57.582

Ejemplares similares